QUAKER CHEMICAL CORP — Director's Dealing 2020

Nov 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: QUAKER CHEMICAL CORP (KWR)
CIK: 0000081362
Period of Report: 2020-11-18

Reporting Person: Hall Mary Dean (SVP, CFO and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-18	Common Stock	M	3838	$72.12	Acquired	9846	Direct
2020-11-18	Common Stock	S	3873	$253.73	Disposed	5973	Direct
2020-11-18	Common Stock	M	2445	$134.60	Acquired	8418	Direct
2020-11-18	Common Stock	S	2167	$255.05	Disposed	6251	Direct
2020-11-18	Common Stock	S	400	$255.70	Disposed	5851	Direct
2020-11-18	Common Stock	S	1400	$258.57	Disposed	4451	Direct
2020-11-18	Common Stock	S	387	$259.25	Disposed	4064	Direct
2020-11-18	Common Stock	S	404	$260.35	Disposed	3660	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-18	Employee Stock Option (right to buy)	$72.12	M	3838	Disposed	2023-02-23	Common Stock (3838)	Direct
2020-11-18	Employee Stock Option (right to buy)	$134.60	M	2445	Disposed	2024-02-27	Common Stock (2445)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	56	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.45 to $254.43, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.46 to $255.343, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.47 to $256.04, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.00 to $258.83, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.00 to $259.93, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.03 to $260.76, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.

F7: Information based on reporting person's Plan Statement as of September 30, 2020.

F8: The options for this grant vested in three annual installments: 1,280 shares on February 23, 2017; 1,279 shares on February 23, 2018; and 1,279 shares on February 23, 2019.

F9: The options for this grant vested in three annual installments: 815 shares on February 27, 2018; 815 shares on February 27, 2019; and 815 shares on February 27, 2020.